These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structure-based engineering of E. coli galactokinase as a first step toward in vivo glycorandomization. Yang J; Fu X; Liao J; Liu L; Thorson JS Chem Biol; 2005 Jun; 12(6):657-64. PubMed ID: 15975511 [TBL] [Abstract][Full Text] [Related]
4. Glycorandomization: A promising diversification strategy for the drug development. Goel B; Tripathi N; Mukherjee D; Jain SK Eur J Med Chem; 2021 Mar; 213():113156. PubMed ID: 33460832 [TBL] [Abstract][Full Text] [Related]
9. Exploiting the rationale behind substrate recognition by promiscuous thermophilic NDP-sugar pyrophosphorylase for expanding glycorandomization: an Gogoi P; Mordina P; Kanaujia SP J Biomol Struct Dyn; 2021 Oct; 39(16):6099-6111. PubMed ID: 32692307 [TBL] [Abstract][Full Text] [Related]
10. A general, iterative, and modular approach toward carbohydrate libraries based on ruthenium-catalyzed oxidative cyclizations. Niggemann M; Jelonek A; Biber N; Wuchrer M; Plietker B J Org Chem; 2008 Sep; 73(18):7028-36. PubMed ID: 18707173 [TBL] [Abstract][Full Text] [Related]
11. Colchicine glycorandomization influences cytotoxicity and mechanism of action. Ahmed A; Peters NR; Fitzgerald MK; Watson JA; Hoffmann FM; Thorson JS J Am Chem Soc; 2006 Nov; 128(44):14224-5. PubMed ID: 17076473 [TBL] [Abstract][Full Text] [Related]